Rhenman & Partners Asset Management’s Guardant Health GH Stock Holding History

Rhenman & Partners Asset Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.4M	Buy	145,000 +65,000	+81%	+$6.53M	1.65%	18
2025 Q4	$8.17M	Buy	80,000 +30,000	+60%	+$2.68M	0.76%	52
2025 Q3	$3.12M	Buy	+50,000	New	+$2.72M	0.35%	74
2022 Q4	–	Sell	-65,000	Closed	-$3.22M	–	94
2022 Q3	$3.22M	Sell	65,000 -30,000	-32%	-$1.54M	0.34%	76
2022 Q2	$3.83M	Hold	95,000	–	–	0.44%	62
2022 Q1	$6.29M	Sell	95,000 -105,000	-53%	-$7.19M	0.62%	54
2021 Q4	$20M	Sell	200,000 -5,000	-2%	-$517K	1.33%	30
2021 Q3	$25.6M	Buy	205,000 +30,000	+17%	+$3.56M	1.8%	16
2021 Q2	$21.7M	Sell	175,000 -50,000	-22%	-$6.73M	1.48%	26
2021 Q1	$34.3M	Buy	225,000 +55,000	+32%	+$8.31M	2.39%	9
2020 Q4	$21.9M	Sell	170,000 -70,000	-29%	-$8.05M	1.79%	19
2020 Q3	$26.8M	Buy	240,000 +55,000	+30%	+$5.03M	2.39%	6
2020 Q2	$15M	Buy	185,000 +10,000	+6%	+$806K	1.62%	24
2020 Q1	$12.2M	Buy	175,000 +19,732	+13%	+$1.51M	1.71%	20
2019 Q4	$12.1M	Buy	155,268 +120,268	+344%	+$8.67M	1.33%	31
2019 Q3	$2.23M	Buy	+35,000	New	+$3.08M	0.28%	74

Other funds holding GH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rhenman & Partners Asset Management's GH Position: Q1 2026 in Review

Rhenman & Partners Asset Management increased its Guardant Health (GH) stake by 81% in Q1 2026, buying an estimated $6.53M and bringing the position to 145,000 shares worth $13.4M. The position accounts for 1.65% of the portfolio, ranked #18.

Rhenman & Partners Asset Management first reported a position in GH in Q3 2019 and has held it in 16 quarters since. The position peaked at $34.3M in Q1 2021. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

Rhenman & Partners Asset Management held 145,000 shares of Guardant Health worth $13.4M as of Q1 2026.
Rhenman & Partners Asset Management bought 65,000 Guardant Health shares in Q1 2026, an estimated $6.53M.
Guardant Health made up 1.65% of Rhenman & Partners Asset Management's portfolio in Q1 2026, its #18 holding.
Rhenman & Partners Asset Management first reported a position in Guardant Health in Q3 2019 and has held it in 16 quarters since.
Rhenman & Partners Asset Management's Guardant Health position peaked at $34.3M in Q1 2021.
481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Rhenman & Partners Asset Management's 13F filing for Q1 2026, filed 14 May 2026.